Counterfeit hope or bridging the gap? Ethical challenges in patient-sourced topical ruxolitinib for vitiligo.
Nikookam Y, Potluru A, Guckian J
Clinical and Experimental DermatologyIn the feed 10 Sep 2026, published online 10 Sep 2026, issue 2026 Sep 10, added to PubMed 10 Sep 2026
Topics: Pigmentary disordersPractice, education & researchEthicsJAK inhibitors & other targeted pillsTopical treatments
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42717803 · DOI 10.1093/ced/llag304